https://www.selleckchem.com/pr....oducts/fluzoparib.ht
mune states and the development and severity of disease as well as the impact on the selection of immunotherapy strategies are discussed in our review. Rhabdomyolysis (RM) has been associated with many viral infectious diseases, and associated with poor outcomes. We aim to evaluate the clinical features and outcomes of RM in patients with coronavirus disease 2019 (COVID-19). This was a single-center, retrospective, cohort study of 1,014 consecutive hospitalized patients with confirmed COVID-19 at the Huoshenshan Hospital in Wuhan, Ch
Like
Comment
Share
